Mitsubishi to build 1,000 humanoids per month

PLUS: AI² Robotics raises $735M, ForSight completes first fully robotic cataract surgery, and UV robots that work at night


Mitsubishi to build 1,000 humanoids per month

Welcome back to your Robot Briefing

Mitsubishi Motors just announced it will mass-produce humanoid robots at 1,000 units per month starting in 2027, turning its Kyoto engine plant into a factory for factory workers. The Japanese automaker signed an MOU with Tokyo startup Highlanders to co-develop bots for its own assembly lines, and potentially sell them to others.

This isn't just another pilot program or proof-of-concept. When a legacy automaker commits manufacturing capacity to building humanoids at scale, the question shifts from whether these machines can work to whether the unit economics actually pencil out at volume.

In today's Robot update:

Mitsubishi Motors commits to 1,000 humanoids monthly
AI² Robotics raises $735M for wheeled humanoids
ForSight completes first fully autonomous cataract surgery
TRIC deploys UV pest-control bots for overnight farming
News

Mitsubishi Motors to mass-produce humanoid robots at 1,000 units per month

Snapshot: Mitsubishi Motors signed an MOU with Tokyo startup Highlanders to co-develop humanoid robots for its own factories and potentially mass-produce them at 1,000 units monthly starting in 2027 at its Kyoto engine plant. This marks the first announced partnership between a carmaker and robotics startup explicitly targeting high-volume humanoid manufacturing, not just deployment.

Breakdown:

Mitsubishi will build and assemble the robots in-house at a repurposed Kyoto facility, starting with welding, logistics, and engine assembly tasks before potentially selling units to other manufacturers.
The automaker has already invested in Highlanders (amount undisclosed) and may commit additional capital as the partnership develops through 2027.
Production capacity of 1,000 units per month would represent serious industrial scale, far beyond the pilot quantities most automakers are currently testing with external suppliers like BMW's arrangement with Figure.

Takeaway: A tier-two automaker committing to mass production infrastructure shifts the conversation from "testing humanoids" to "building an industry." If Mitsubishi hits its 2027 timeline, operations leaders will face procurement decisions about humanoid suppliers in the near future, within 18-24 months.

News

AI² Robotics raises $735M at $2.8B valuation for wheeled humanoid robots

Snapshot: Shenzhen-based AI² Robotics secured $735 million at a $2.8 billion valuation from a mix of Chinese government funds, industrial corporations, and financial firms to scale production of its AlphaBot wheeled humanoid equipped with a proprietary vision-language-action model. The company deliberately chose wheels over legs to reduce costs, improve durability, and avoid regulatory barriers in logistics, manufacturing, biotech, and retail environments.

Breakdown:

AlphaBot features over 34 degrees of freedom with a custom waist-leg lifting mechanism that adjusts torso height, trading stair-climbing ability for mechanical simplicity and lower production costs.
The robot runs Alpha Brain, AI²'s proprietary vision-language-action model that handles real-time spatial reasoning and multi-step task planning without requiring task-specific programming.
Investors include the National Small and Medium Enterprises Development Fund, Sino Biopharmaceutical, Moutai Group, CICC Capital, and GSR Ventures, signaling state-backed strategic importance alongside commercial interest.

Takeaway: The wheeled design choice and $2.8 billion valuation suggest the market is splitting between technically impressive legged robots and commercially pragmatic wheeled systems for structured environments. Operations leaders should evaluate whether their facilities actually need legs or if wheels with lifting mechanisms deliver 80 percent of the value at a fraction of the complexity.

News

ForSight Robotics completes first fully robotic cataract surgery from start to finish

Snapshot: ForSight Robotics' JASPER Platform completed a robot-assisted cataract surgery in a human patient in Manila, handling every step from initial incision to closure rather than partial tasks. The procedure was controlled by a skilled surgeon with AI-assisted mistake prevention, not autonomous operation, addressing the global shortage of trained ophthalmic surgeons.

Breakdown:

Previous ophthalmic robotic systems only automated portions of cataract procedures, while JASPER performed the complete workflow under surgeon control with advanced imaging, precision, and motion scaling.
Dr. Alexey Rapoport performed the procedure with Dr. Robert Edward T. Ang of the Asian Eye Institute serving as principal investigator, marking the first full-procedure demonstration in human patients.
Cataracts are the world's leading cause of blindness with treatment requiring surgery, but the gap between available surgeons and patient volume continues to widen globally.

Takeaway: Full-procedure robotic surgery in a high-volume specialty like cataracts signals that surgical robotics is moving from niche applications to scalable solutions for workforce shortages, with clinics in surgeon-scarce regions the most likely early adopters.

News

TRIC Robotics raises $5.5M to deploy UV-light pest control robots that work while farmers sleep

A comparison infographic detailing how TRIC Robotics' nighttime UV-C robots reduce strawberry pesticide use by 70 percent, contrasting this with USDA data showing 99 percent of conventional strawberries contain pesticide residues.

Image Source: There's A Robot For That

Snapshot: San Luis Obispo-based TRIC Robotics closed a $5.5 million seed round led by Version One Ventures to expand autonomous robots that treat strawberry fields with UV-C light at night, reducing pesticide use up to 70 percent. The company operates nine robots across hundreds of acres in California's Central Coast with a service model where farmers pay per treatment rather than buying equipment.

Breakdown:

TRIC's Luna robots use UV-C light to damage pest and pathogen DNA at night when pollinators are inactive and organisms cannot repair UV damage without sunlight, treating approximately 30 acres per robot per night.
The nighttime operating window eliminates scheduling conflicts with daytime farm operations, and the robotics-as-a-service model removes upfront capital requirements for farmers who pay roughly what conventional pesticide applications cost.
USDA scientists found that 99 percent of conventional strawberry samples contained detectable pesticide residues, with some showing residues from more than 20 different chemicals, making the crop among the most chemically intensive in American agriculture.

Takeaway: The product-market fit is nearly perfect: robots work off-hours, eliminate labor scheduling conflicts, and deliver chemical reduction without requiring behavior change from farmers. Operations leaders in agriculture or other 24-hour facilities should examine whether their overnight downtime represents untapped opportunity for robotic systems that complement rather than compete with existing workflows.

Other Top Robot Stories

Brave1 launched a grant competition to develop bipedal robots built exclusively for military use, making Ukraine's state defense-tech cluster the first government to fund combat humanoids as a distinct procurement category, with breakthrough projects eligible for over 100 million hryvnias as factory-proven platforms get tested against GPS-denied, jamming-heavy trench terrain.

1X unveiled advanced hands for its Neo humanoid featuring 25 actuated degrees of freedom and tendon-driven motion with high-resolution tactile sensors, plus IP68 sealing that allows the robot to perform tasks like cooking and self-cleaning in household environments.

Medicaroid received the CE mark for its Hinotori surgical robot system, authorizing the Kawasaki-Sysmex joint venture to compete with Intuitive Surgical across urology, general surgery, gynecology and thoracic procedures in Europe, the Middle East and Africa.

Stereotaxis completed its acquisition of French surgical robotics company Robocath in a deal valued at up to $45 million, combining expertise in robotic magnetic navigation and endovascular interventions to accelerate development for electrophysiology and interventional cardiology procedures.

Deploying humanoids this year? Our free Facility Readiness Checklist walks your site before the robot arrives, 77+ items, one complete toolkit module.

🤖 Your robotics thought for today:

Mitsubishi is converting an engine plant to build 1,000 humanoids monthly. AI² just raised $735M for wheeled bots that can't climb stairs. One chose manufacturing scale over perfection, the other chose practicality over capability. The companies betting biggest aren't chasing the most impressive demos—they're solving for unit economics and deployment speed.

Which strategy actually scales?

Until Wednesday,
Uli

Mitsubishi to build 1,000 humanoids per month

Great! Check your inbox and click the link to confirm.
Please enter a valid email address.